Companies

STRATA Skin Sciences, Inc.

SSKN · CIK 0001051514 · operating

$0.21-10.64%Last updated Feb 27, 10:04 PM

Key Statistics

Valuation

Market Cap$1.19M
P/E
Fwd P/E-0.16
PEG
P/S0.04
P/B0.84
EV/EBITDA-6.07
EV/Rev0.35

Profitability

Gross Margin56.85%
Op. Margin-27.58%
Net Margin-30.05%
ROE-202.86%
ROA-27.90%
FCF Margin-4.31%

Financial Health

Current Ratio1.13
Debt/Equity6.27
Free Cash Flow-$1.45M
Div. Yield

Growth & Other

Revenue Growth0.61%
EPS Growth-754.84%
Beta0.32
52W High$3.86
52W Low$0.12

About STRATA Skin Sciences, Inc.

STRATA Skin Sciences is a medical technology company that develops and commercializes dermatological treatment devices for conditions including psoriasis, vitiligo, and acne. The company's primary product portfolio consists of the XTRAC excimer laser and VTRAC lamp systems, which deliver targeted light therapy for various skin disorders, and the TheraClear acne therapy system designed to treat mild to moderate inflammatory and comedonal acne. These devices are used in dermatology clinics and group practices across multiple regions.

The company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment, reflecting both consumable and capital equipment revenue streams. STRATA serves dermatologists and dermatological group clinics as its primary customer base.

Based in Horsham, Pennsylvania, the company maintains a presence across the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The organization has 106 full-time employees. STRATA Skin Sciences was incorporated in Delaware in 1989 and was formerly known as MELA Sciences, Inc. until rebranding in January 2016. The company is traded on the OTC market.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-2.65$-2.65-754.8%
2023$-0.31$-0.31
2022
2021
2020$-0.13$-0.13-18.2%
2019$-0.11$-0.11+26.7%
2018$-0.15$-0.15+94.7%
2017$-2.85$-2.85-280.0%
2016$-0.75$-0.31
2015
2014
2013
2012
2011

Annual Reports (10-K) · 20 filings

Report DateFiledAccession Number
2024-12-312025-03-280001140361-25-010772SEC ↗
2023-12-312024-03-280001140361-24-015754SEC ↗
2022-12-312023-03-310001140361-23-015429SEC ↗
2021-12-312022-03-210001140361-22-010347SEC ↗
2020-12-312021-03-250001051514-21-000018SEC ↗
2019-12-312020-03-170001051514-20-000015SEC ↗
2018-12-312019-10-300001051514-19-000084SEC ↗
2017-12-312018-04-020001051514-18-000012SEC ↗
2016-12-312017-03-130001051514-17-000014SEC ↗
2015-12-312016-03-150001051514-16-000048SEC ↗
2014-12-312015-03-300001615774-15-000575SEC ↗
2013-12-312014-03-170001193125-14-102619SEC ↗
2012-12-312013-03-050001193125-13-091842SEC ↗
2011-12-312012-03-090001193125-12-106195SEC ↗
2010-12-312011-03-030000950123-11-021697SEC ↗
2009-12-312010-03-040000950123-10-020941SEC ↗
2008-12-312009-03-020000950123-09-003799SEC ↗
2007-12-312008-03-120000950123-08-002847SEC ↗
2006-12-312007-03-150000950123-07-003922SEC ↗
2005-12-312006-03-290000950123-06-003863SEC ↗